COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,091 Articles (22,658 medRxiv, 8,433 bioRxiv)

Most recent first Previous |  Page 1304: Articles 13031-13040  | Next

Controlled administration of aerosolized SARS-CoV-2 to K18-hACE2 transgenic mice uncouples respiratory infection and anosmia from fatal neuroinvasion
Fumagalli, V., Rava, M., Marotta, D., Di Lucia, P., Laura, C., Sala, E., Grillo, M., Bono, E., Giustini, L., Perucchini, C., Mainetti, M., Sessa, A., Garcia-Manteiga, J., Donnici, L., Manganaro, L., Delbue, S., Broccoli, V., De Francesco, R., D'Adamo, P., Kuka, M., Guidotti, L., Iannacone, M.
10.1101/2021.08.06.455382 — Posted: 2021-08-06
Learning torus PCA based classification for multiscale RNA backbone structure correction with application to SARS-CoV-2
Wiechers, H., Eltzner, B., Mardia, K. V., Huckemann, S. F.
10.1101/2021.08.06.455406 — Posted: 2021-08-06
RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection
Marx, S., Kuemmerer, B. M., Gruetzner, C., Kato, H., Schlee, M., Bartok, E., Renn, M., Hartmann, G.
10.1101/2021.08.06.455405 — Posted: 2021-08-06
The Inherent Flexibility of Receptor Binding Domains in SARS-CoV-2 Spike Protein
Dokainish, H. M., Re, S., Mori, T., Kobayashi, C., Jung, J., Sugita, Y.
10.1101/2021.08.06.455384 — Posted: 2021-08-06
Small-molecule ligands can inhibit -1 programmed ribosomal frameshifting in a broad spectrum of coronaviruses
Munshi, S., Neupane, K., Ileperuma, S. M., Halma, M. T., Kelly, J. A., Halpern, C. F., Dinman, J. D., Loerch, S., Woodside, M. T.
10.1101/2021.08.06.455424 — Posted: 2021-08-06 Discussion: Offsite
Development and performance evaluation of a low-cost in-house rRT-PCR assay in Ecuador for the detection of SARS-CoV-2
Salinas, M., Aguirre, D., De la Torre, D., Perez-Galarza, J., Pibaque, R., Beltran, P., Veloz, T., Baldeon, L.
10.1101/2021.08.03.21260966 — Posted: 2021-08-06
Helmet noninvasive ventilation for COVID-19 patients (Helmet-COVID): study protocol for a multicenter randomized controlled trial
Arabi, Y., Tlayjeh, H., Aldekhyl, S., Al-Dorzi, H., Abdukahil, S. A., Al Harbi, M. K., Al Haji, H., Al Mutairi, M., Al Zumai, O., Al Qasim, E., Al Wehaibi, W., Al Qahtani, S., Al-Hameed, F., Chalabi, J., Alshahrani, M., Alharthy, A., Mady, A., Bin Eshaq, A., Al Bshabshe, A., Al Aseri, Z., Al Duhailib, Z., Kharaba, A., Alqahtani, R., Al Ghamdi, A., Altalag, A., Alghamdi, K., Almaani, M., Algethamy, H., Al Aqeily, A., Al Baseet, F., Al Samannoudi, H., Al Obaidi, M., Ismaiel, Y., Al-Fares, A.
10.1101/2021.08.04.21260420 — Posted: 2021-08-06
Quantitative SARS-CoV-2 tracking of variants Delta, Delta plus, Kappa and Beta in wastewater by allele-specific RT-qPCR
Lee, W. L., Gu, X., Armas, F., Chandra, F., Chen, H., Wu, F., Leifels, M., Xiao, A., Chua, F. J. D., Kwok, G. W., Jolly, S., Lim, C. Y. J., Thompson, J., Alm, E. J.
10.1101/2021.08.03.21261298 — Posted: 2021-08-06
Limited variation between SARS-CoV-2-infected individuals in domain specificity and relative potency of the antibody response against the spike glycoprotein
Van Ert, H. A., Bohan, D. W., Rogers, K. J., Fili, M., Rojas Chavez, A. R., Qing, E., Han, C., Dempewolf, S. M., Hu, G., Schwery, N., Sevcik, K. M., Ruggio, N., Boyt, D., Pentella, M., Gallagher, T., Jackson, J. B., Merrill, A. E., Knudson, C. M., Brown, G., Maury, W., Haim, H.
10.1101/2021.08.04.455181 — Posted: 2021-08-05
Vaccination with B.1.1.7, B.1.351 and P.1 variants protects mice from challenge with wild type SARS-CoV-2
Amanat, F., Strohmeier, S., Meade, P., Dambrauskas, N., Mühlemann, B., Smith, D. J., Vigdorovich, V., Sather, D. N., Coughlan, L., Krammer, F.
10.1101/2021.08.05.455212 — Posted: 2021-08-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).